Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-market Registry Study to Assess Safety and Performance of RefluxStop™ in the Treatment of Gastroesophageal Reflux Disease (GERD) in General Hospital Practice

NCT05870163 is registered in ClinicalTrials.gov with Implantica CE Reflux Ltd. as lead sponsor.

NCT NCT05870163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-market Registry Study to Assess Safety and Performance of RefluxStop™ in the Treatment of Gastroesophageal Reflux Disease (GERD) in General Hospital Practice
Lead sponsor
Implantica CE Reflux Ltd.
Phase
Observational
Overall status
Recruiting
Start date
February 20, 2023
Completion date
December 31, 2029
Enrollment
2,500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease (gerd)